DermaSensor Secures $16M to Scale AI-Powered Skin Cancer Detection in Primary Care
DermaSensor Inc., a medical device technology company transforming skin cancer detection for frontline care, today announced it has raised $16 million in Series B funding to fuel the commercial expansion of its FDA cleared, non-invasive skin cancer detection solution.










